InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Source: ShutterstockSpero Therapeutics (NASDAQ:SPRO) stock is climbing higher on Wednesday thanks to positive feedback from the FDA.
That concerns plans to resubmit tebipenem HBr for the treatment of complicated urinary tract infection (cUTI). During a Type A meeting, the FDA said positive results from a Phase 3 clinical trial could support approval of tebipenem HBr for cUTI.
It’s worth noting that Spero Therapeutics has already conducted a Phase 3 clinical trial of tebipenem HBr for cUTI. The FDA’s suggestion is for a second Phase 3 clinical trial to further back up results.
During that same meeting, Spero Therapeutics and the FDA hashed out some of the details of a new clinical trial. This could have that study being the subject of a Special Protocol Assessment. The trial will also need approval once plans are finalized.
SPRO Plans to Further Development of the Antibiotic
Spero Therapeutics notes that it intends to move forward with the clinical development and commercialization of tebipenem HBr. The company says that it will be seeking an external partnership as part of this effort.
News of the FDA meeting has SPRO stock seeing incredibly heavy trading on Wednesday. As of this writing, more than 38 million shares of the stock have been traded. To put that in perspective, the company’s daily average trading volume is closer to 1.6 million shares.
SPRO stock is up 14.9% as of Wednesday morning but is down 91.4% since the start of the year.
Investors searching for all of the latest stock market news are in luck!
We’ve got them covered with our daily dives into the stock market. For Wednesday, that includes what has shares of software stocks, Pinterest (NYSE:PINS), and Coupa Software (NASDAQ:COUP) on the move today. You can get up to speed on that news at the links below!
More Wednesday Stock Market News
- Why Are Software Stocks Climbing Higher Today?
- Pinterest (PINS) Stock Pops on Wolfe Research Upgrade
- Coupa (COUP) Stock Gains 10% on Strong Earnings, Stock Buyback
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
More From InvestorPlace
- Buy This $5 Stock BEFORE This Apple Project Goes Live
- The Best $1 Investment You Can Make Today
- Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
- It doesn’t matter if you have $500 or $5 million. Do this now.
The post Why Is Spero Therapeutics (SPRO) Stock Up 15% Today? appeared first on InvestorPlace.